Variants of NOD1 and NOD2 genes display opposite associations with familial risk of crohn's disease and anti-saccharomyces cerevisiae antibody levels

Inflammatory Bowel Diseases

Volumn 18, Issue 3, 2012, Pages 430-438

  Vasseur, Francis ^a,b,c,d   Sendid, Boualem ^a,b,d,e,f   Jouault, Thierry ^a,b,e   Standaert Vitse, Annie ^a,b,g,h   Dubuquoy, Laurent ^a,b,e   Francois, Nadine ^d,f   Gower Rousseau, Corinne ^c,d,i   Desreumaux, Pierre ^a,b,e,j   Broly, Franck ^a,b,d,k   Vermeire, Severine ^l   Colombel, Jean Fréderic ^a,b,d,e,j   Poulain, Daniel ^a,b,d,e,f  

^a UNIV LILLE   (France)

^b UDSL   (France)

^c EA2694 ^*  (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ DE LILLE   (France)

^f Service de Parasitologie Mycologie   (France)

^g INSERM U1019   (France)

^h INSTITUT PASTEUR DE LILLE   (France)

ⁱ INSERM   (France)

^j Service des Maladies de l'Appareil Digestif et de la Nutrition   (France)

^k France Institut Pasteur de Lille   (France)

^l UNIVERSITY HOSPITALS LEUVEN   (Belgium)

more..

Author keywords

ASCA; Crohn's disease; genetics; NOD1; NOD2

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; FUNGUS ANTIBODY;

ALLELE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SACCHAROMYCES CEREVISIAE;

ANTIBODIES, FUNGAL; CHI-SQUARE DISTRIBUTION; CROHN DISEASE; GENE FREQUENCY; GENOTYPE; HUMANS; MONTE CARLO METHOD; MUTATION; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, GENETIC; SACCHAROMYCES CEREVISIAE;

EID: 84857373520     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21817     Document Type: Article

References (25)

1. Clarke TB, Davis KM, Lysenko ES, et al. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med. 2010; 16: 228-231.
2. Dharancy S, Body-Malapel M, Louvet A, et al. Neutrophil migration during liver injury is under nucleotide-binding oligomerization domain 1 control. Gastroenterology. 2010; 138: 1546-1556, 1556 e1541-1545.
3. Zouali H, Lesage S, Merlin F, et al. CARD4/NOD1 is not involved in inflammatory bowel disease. Gut. 2003; 52: 71-74. (Pubitemid 36020768)
4. Van Limbergen J, Russell RK, Nimmo ER, et al. Contribution of the NOD1/CARD4 insertion/deletion polymorphism +32656 to inflammatory bowel disease in northern Europe. Inflamm Bowel Dis. 2007; 13: 882-889. (Pubitemid 47203866)
5. McGovern DP, Hysi P, Ahmad T, et al. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet. 2005; 14: 1245-1250. (Pubitemid 40744484)
6. Annese V, Andreoli A, Andriulli A, et al. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study. Am J Gastroenterol. 2001; 96: 2407-2412. (Pubitemid 32769203)
7. Devlin SM, Yang H, Ippoliti A, et al. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives. Gastroenterology. 2007; 132: 576-586. (Pubitemid 46274655)
8. Sendid B, Quinton JF, Charrier G, et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol. 1998; 93: 1306-1310. (Pubitemid 29076932)
9. Israeli E, Grotto I, Gilburd B, et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut. 2005; 54: 1232-1236. (Pubitemid 41192480)
10. Standaert-Vitse A, Sendid B, Joossens M, et al. Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol. 2009; 104: 1745-1753.
11. Gower-Rousseau C, Salomez JL, Dupas JL, et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut. 1994; 35: 1433-1438. (Pubitemid 24310907)
12. Molinie F, Gower-Rousseau C, Yzet T, et al. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Gut. 2004; 53: 843-848. (Pubitemid 38662134)
13. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005; 19 (suppl A): 5-36.
14. Sendid B, Colombel JF, Jacquinot PM, et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol. 1996; 3: 219-226. (Pubitemid 26104780)
15. Joossens M, Van Steen K, Branche J, et al. Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn's disease. Inflamm Bowel Dis. 2010; 16: 58-67.
16. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005; 21: 263-265. (Pubitemid 40202029)
17. Abecasis GR, Cardon LR, Cookson WO,. A general test of association for quantitative traits in nuclear families. Am J Hum Genet. 2000; 66: 279-292. (Pubitemid 30481489)
18. Sham PC, Curtis D,. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet. 1995; 59: 97-105.
19. Pascoe L, Zouali H, Sahbatou M, et al. Estimating the odds ratios of Crohn disease for the main CARD15/NOD2 mutations using a conditional maximum likelihood method in pedigrees collected via affected family members. Eur J Hum Genet. 2007; 15: 864-871. (Pubitemid 47109046)
20. Halfvarson J, Standaert-Vitse A, Jarnerot G, et al. Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease. Gut. 2005; 54: 1237-1243. (Pubitemid 41192481)
21. Riis L, Vind I, Vermeire S, et al. The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients. Inflamm Bowel Dis. 2007; 13: 24-32. (Pubitemid 46080006)
22. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology. 2002; 122: 867-874. (Pubitemid 34267268)
23. Canto E, Ricart E, Busquets D, et al. Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype. World J Gastroenterol. 2007; 13: 5446-5453. (Pubitemid 47610988)
24. Laird NM, Lange C,. Family-based designs in the age of large-scale gene-association studies. Nat Rev Genet. 2006; 7: 385-394.
25. Hugot JP, Zaccaria I, Cavanaugh J, et al. Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am J Gastroenterol. 2007; 102: 1259-1267. (Pubitemid 46802011)